Search

Displaying results 4161 - 4170 of 7687 in total
  1. Drug

    Laquinimod

    go.drugbank.com/drugs/DB06685
    Investigational

    Laquinimod is an immunomodulator developed by Active Biotech and produced by Teva Pharmaceutical Industries. … It is currently under development in phase III trials for treatment of multiple sclerosis as an oral therapy, like fingolimod.

  2. Drug

    Tangerine peel

    go.drugbank.com/drugs/DB14316
    Investigational

    It is not an approved drug.

  3. Drug

    Coconut oil

    go.drugbank.com/drugs/DB14322
    Investigational

    It is not an approved drug.

  4. Drug

    Sunflower oil

    go.drugbank.com/drugs/DB14329
    Investigational

    It is not an approved drug.

  5. Drug

    Bergamot oil

    go.drugbank.com/drugs/DB14335
    Investigational

    It is not an approved drug.

  6. Drug

    Chondrus crispus

    go.drugbank.com/drugs/DB14367
    Investigational

    It is not an approved drug.

  7. Drug

    HMI-103

    go.drugbank.com/drugs/DB17684
    Investigational

    HMI-102 is an investigational gene therapy designed to encode the phenylalanine-4-hydroxylase (PAH) gene, mutated in people with phenylketonuria.

  8. Drug

    AMB-301

    go.drugbank.com/drugs/DB18094
    Experimental

    AMB-301 is an AAV gene therapy delivering E-selectin.[L48101] It is under investigation for the treatment of Buerger disease.

  9. Drug

    Col-Treg

    go.drugbank.com/drugs/DB18451
    Experimental

    Col-Treg is an autologous T-cell therapy comprising type I regulatory T-cells specific for human type II collagen.[A261635]

  10. Drug

    RCT1100

    go.drugbank.com/drugs/DB18830
    Investigational

    RCT1100 is an investigational mRNA-based therapeutic that aims to treat primary ciliary dyskinesia caused by pathogenic mutations in DNAI1.[L50788]